Effectiveness of maternal antiviral prophylaxis in mother‐to‐child transmission of hepatitis B virus (HBV) has been extensively explored in studies where standard immunoprophylaxis is well secured to the newborns. This real‐world… Click to show full abstract
Effectiveness of maternal antiviral prophylaxis in mother‐to‐child transmission of hepatitis B virus (HBV) has been extensively explored in studies where standard immunoprophylaxis is well secured to the newborns. This real‐world study aims to test if maternal antiviral prophylaxis can safeguard the newborn when immunoprophylaxis administration was delayed or missed.
               
Click one of the above tabs to view related content.